An injectable 1.0 mg dose does not equal an oral 1.0 mg dose in your bloodstream
Endogenous GLP-1 alters postprandial functional connectivity between homeostatic and reward-related brain regions involved in regulation of appetite in healthy lean males: a pilot study
Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease
Several conceptual models may guide future clinical trials and practice: (i) Parallel model: Behavioral therapy and pharmacotherapy begin at the same time
Several recent Alzheimers clinical trials with GLP-1s have not shown clear improvements in cognitive test scores or consistent reductions in tau and amyloid beta, despite some positive changes in brain metabolism and inflammation
Mech Ageing Dev 126(3):389398 Cascalheira JF, Gonalves M, Barroso M, Castro R, Palmeira M, Serpa A, Dias-Cabral AC, Domingues FC, Almeida S (2015) Association of the transcobalamin II gene 776CG polymorphism with Alzheimers type dementia: dependence on the 5, 10-methylenetetrahydrofolate reductase 1298AC polymorphism genotype
